Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  palladium Pd 103
Find trials that include:  Any drugs shown
Trial Status:  Active
Results 1-7 of 7 for your search:
Start Over
Low Dose Supplemental External Radiation With Pd-103 Versus Pd-103 Alone for Prostate Cancer
Phase: Phase III
Type: Treatment
Status: Active
Age: 40 to 80
Sponsor: Other
Protocol IDs: 04-8-10, NCT00241384
Pd-103 Dose De-Escalation for Early Stage Prostate Cancer: A Prospective Randomized Trial
Phase: Phase III
Type: Treatment
Status: Active
Age: No age specified
Sponsor: Other
Protocol IDs: 05-8-3, NCT00247312
I-125 Versus Pd-103 for Medium Risk Prostate Cancer
Phase: Phase III
Type: Treatment
Status: Active
Age: 40 to 90
Sponsor: Other
Protocol IDs: 02-4407-V04, NCT00486499
Partial Breast Irradiation Using Interstitial Permanent Palladium-103 Seed Implant
Phase: Phase II
Type: Treatment
Status: Approved-not yet active
Age: 55 to 80
Sponsor: Other
Protocol IDs: H14-02175, NCT02297672
Implant Radiation Therapy or Surgery in Treating Patients With Prostate Cancer
Phase: No phase specified
Type: Educational/Counseling/Training, Treatment
Status: Active
Age: Adult
Sponsor: Other
Protocol IDs: CDR0000668741, USCTU-SABRE1, ISRCTN88144169, EU-21018, CRUK-CTAAC-C328/A8692, NCRN-11061813, US-SABRE 1, NCT01098331
A Registry Study of Permanent Breast Seed Implant
Phase: No phase specified
Type: Treatment
Status: Active
Age: 50 and over
Sponsor: Other
Protocol IDs: PBSI Registry, NCT01106521
Pilot Study of Partial Breast Irradiation Utilizing Permanent Breast Seed Implant to Treat Breast Cancer
Phase: No phase specified
Type: Supportive care, Treatment
Status: Approved-not yet active
Age: 60 and under
Sponsor: Other
Protocol IDs: BCCA-H09-01053, NCT01191164
Start Over